Financing follows Torres's CrossBridge Bio acquisition by Eli Lilly and supports translation of ARTAN Bio's programmable approach to mutation-driven aging biology. ST. PETERSBURG, ...

Gene editing can repair mutations that prematurely halt protein synthesis, resulting in incomplete peptides that cause various diseases. However, other approaches achieve the same effect without ...

ARTAN Bio has developed a novel engineered suppressor tRNA system (ARTAN-102) designed to selectively recognize disease-causing nonsense codons and restore normal protein translation. Unlike ...

For decades, biology students have learned one rule about the genetic code that supposedly has no exceptions: three specific DNA sequences act as stop signs, telling the cell’s protein-building ...

Alltrna's leadership team includes CEO Michelle Werner (left), founding CEO and Director Lovisa Afzelius (center) and co-founder and Chief Innovation Officer Theonie Anastassiadis. (Alltrna) Alltrna ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian cells, researchers from Peking University led by Chen Peng from College of ...

The pond at Oxford University Parks is not much to look at. It is a small, artificial freshwater basin on the edge of campus, the kind of place students walk past on the way to lectures. But in April ...